24 related articles for article (PubMed ID: 38432099)
1. Subclinical thyroid dysfunction and fracture risk: a meta-analysis.
Blum MR; Bauer DC; Collet TH; Fink HA; Cappola AR; da Costa BR; Wirth CD; Peeters RP; Åsvold BO; den Elzen WP; Luben RN; Imaizumi M; Bremner AP; Gogakos A; Eastell R; Kearney PM; Strotmeyer ES; Wallace ER; Hoff M; Ceresini G; Rivadeneira F; Uitterlinden AG; Stott DJ; Westendorp RG; Khaw KT; Langhammer A; Ferrucci L; Gussekloo J; Williams GR; Walsh JP; Jüni P; Aujesky D; Rodondi N;
JAMA; 2015 May; 313(20):2055-65. PubMed ID: 26010634
[TBL] [Abstract][Full Text] [Related]
2. The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study.
Aubert CE; Bauer DC; da Costa BR; Feller M; Rieben C; Simonsick EM; Yaffe K; Rodondi N;
Clin Endocrinol (Oxf); 2017 Nov; 87(5):617-626. PubMed ID: 28850708
[TBL] [Abstract][Full Text] [Related]
3. Association Between Thyroid Dysfunction and Incident Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study.
George KM; Lutsey PL; Selvin E; Palta P; Windham BG; Folsom AR
J Endocrinol Metab; 2019 Aug; 9(4):82-89. PubMed ID: 32411312
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Disorders and Peripheral Arterial Disease.
Studen KB; Gaberscek S; Zaletel K; Blinc A; Sabovic M; Schernthaner GH; Anagnostis P; Antignani PL; Jensterle M; Mikhailidis DP; Poredos P
Curr Vasc Pharmacol; 2024; 22(1):36-40. PubMed ID: 37957913
[TBL] [Abstract][Full Text] [Related]
5. Toenail and blood selenium mediated regulation of thyroid dysfunction through immune cells: a mediation Mendelian randomization analysis.
Jiang YJ; Xiong YQ; Huang T; Xiao YX
Front Nutr; 2024; 11():1378969. PubMed ID: 38840695
[TBL] [Abstract][Full Text] [Related]
6. A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancers.
Kang JH; Kueck AS; Stevens R; Curhan G; De Vivo I; Rosner B; Alexander E; Tworoger SS
Obstet Gynecol Int; 2013; 2013():743721. PubMed ID: 23956749
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Dysfunction in Non-Small Cell Lung Cancer With Immune Checkpoint Inhibitors: A Meta-Analysis.
Lin L; Yang F; Lin G; Chen X
J Clin Pharmacol; 2023 Feb; 63(2):210-218. PubMed ID: 36083133
[TBL] [Abstract][Full Text] [Related]
8. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.
Spencer L; Bubner T; Bain E; Middleton P
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011263. PubMed ID: 26387772
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
10. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function.
Tsai K; Ma H; Liang TZ; Xing Y; Chung S; Dorff T; Bell D; Lechner MG
Thyroid; 2024 Feb; 34(2):158-166. PubMed ID: 38069567
[No Abstract] [Full Text] [Related]
11. Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer.
Zhou Y; Xia R; Xiao H; Pu D; Long Y; Ding Z; Liu J; Ma X
Int Immunopharmacol; 2021 Feb; 91():107296. PubMed ID: 33360368
[TBL] [Abstract][Full Text] [Related]
12. Changes in thyroid function and evolution of subclinical thyroid disease in older men.
Tan SY; Chubb SAP; Flicker L; Almeida OP; Golledge J; Hankey GJ; Yeap BB
Clin Endocrinol (Oxf); 2024 Feb; 100(2):170-180. PubMed ID: 38059618
[TBL] [Abstract][Full Text] [Related]
13. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
[TBL] [Abstract][Full Text] [Related]
14. Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study.
Kennedy OJ; Ali N; Lee R; Monaghan P; Adam S; Cooksley T; Lorigan P
Eur J Cancer; 2024 May; 202():113949. PubMed ID: 38432099
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
